Physician profile
Richard Sipes
NPI 1528063252
$56,473.05
in general payments reported to CMS, 2019-2025
10 companies · $747 in 2025
The $747 reported for 2025 was more than what 86% of Addiction Medicine (Internal Medicine) providers received nationally (typical 2025 total: $124).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $20K · 2021: $80.53 · 2022: $109 · 2023: $219 · 2024: $334 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,299.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $55,379.75 | 2019-2025 | Sublocade |
| Braeburn INC. | $471.61 | 2023-2025 | Brixadi |
| Gilead Sciences, INC. | $238.81 | 2025 | Epclusa |
| Janssen Pharmaceuticals, INC | $195.56 | 2024-2025 | Invega Sustenna |
| Alpha Cognition USA, INC. | $56.21 | 2025 | Zunveyl |
| Teva Pharmaceuticals USA, INC. | $42.00 | 2025 | Austedo Xr |
| Alkermes, INC. | $26.41 | 2023 | Vivitrol |
| Axsome Therapeutics, INC. | $23.49 | 2025 | Auvelity |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.21 | 2024 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Sipes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.